vivireber.bsky.social

07 July 2026 11:39

Out now: ATP-competitive inhibitors lock kinases in a pseudo-active conformation and modulate their non-catalytic functions. We show that these on-target, off-machanism effects can cause unexpected phenotypes and how to screen for these effects. Read more at link.springer.com/article/10.1...

Department of Biology, ETH Zurich

eth-dbiol.bsky.social

15 June 2026 16:19

D-BIOL is so proud to share that proteomics researcher Paola Picotti (IMSB) is to be awarded this year’s Otto Naegeli Prize for her research into the molecular causes of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. A well deserved recognition! ethz.ch/en/news-and-...

CRC1678

crc1678.bsky.social

15 June 2026 16:19

🎉 Congratulations to our #CRC1678 project leader Paola Picotti @picottilab.bsky.social on receiving the 2026 Otto Naegeli Prize! Her pioneering LiP‑MS work is transforming how we study protein structure and neurodegeneration.🧪⚗️🧫

Gautam Dey

gautamdey.bsky.social

10 June 2026 07:36

Science really takes a village. Thrilled to share this with my friend @dudinlab.bsky.social, and with our brilliant and fearless teams, our collaborators around the world and our mentors - in my case a special shoutout to Buzz Baum, Jan Ellenberg and @monicabettencourt.bsky.social. 1/2

Institute of Molecular Systems Biology

imsb-eth.bsky.social

01 June 2026 21:25

A new perspective from IMSB's @nzamboni.bsky.social with Theodore Alexandrov. They map out how scaling up metabolomics, bridging single-cell resolution with large population cohorts, will have an impact on biology and medicine. www.nature.com/articles/s41...